BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8186705)

  • 1. The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy.
    Nicholson LV
    Neuromuscul Disord; 1993; 3(5-6):525-31. PubMed ID: 8186705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy.
    Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D
    Arch Dis Child; 1993 May; 68(5):632-6. PubMed ID: 8323331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological evidence for second or somatic mutations as the underlying cause of dystrophin expression by isolated fibres in Xp21 muscular dystrophy of Duchenne-type severity.
    Wallgren-Pettersson C; Jasani B; Rosser LG; Lazarou LP; Nicholson LV; Clarke A
    J Neurol Sci; 1993 Aug; 118(1):56-63. PubMed ID: 8229051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
    Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
    Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.
    Winnard AV; Mendell JR; Prior TW; Florence J; Burghes AH
    Am J Hum Genet; 1995 Jan; 56(1):158-66. PubMed ID: 7825572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
    Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
    Mizuno Y; Nonaka I; Hirai S; Ozawa E
    J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.
    Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
    J Med Genet; 1993 Sep; 30(9):737-44. PubMed ID: 8411068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin expression in Duchenne patients with "in-frame" gene deletions.
    Nicholson LV; Bushby KM; Johnson MA; Gardner-Medwin D; Ginjaar IB
    Neuropediatrics; 1993 Apr; 24(2):93-7. PubMed ID: 8327067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.
    van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ
    Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular deletion patterns in Turkish Duchenne and Becker muscular dystrophy patients.
    Dinçer P; Topaloğlu H; Ayter S; Ozgüç M; Taşdemir HA; Renda Y
    Brain Dev; 1996; 18(2):91-4. PubMed ID: 8733896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of Duchenne muscular dystrophy.
    Topaloğlu H; Dinçer P; Göğüş S; Ayter S; Topçu M
    Brain Dev; 1993; 15(4):313-5. PubMed ID: 8250158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophin in frameshift deletion patients with Becker muscular dystrophy.
    Gangopadhyay SB; Sherratt TG; Heckmatt JZ; Dubowitz V; Miller G; Shokeir M; Ray PN; Strong PN; Worton RG
    Am J Hum Genet; 1992 Sep; 51(3):562-70. PubMed ID: 1496988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a dystrophin gene deletion by amplification of mRNA isolated from DMD myotubes cultured in vitro.
    Ehrenpreis J; Hillers M; Junkes B; Pfordt M; Schwinger E; Vosberg HP
    Genomics; 1991 Jul; 10(3):551-7. PubMed ID: 1889805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.
    Béroud C; Tuffery-Giraud S; Matsuo M; Hamroun D; Humbertclaude V; Monnier N; Moizard MP; Voelckel MA; Calemard LM; Boisseau P; Blayau M; Philippe C; Cossée M; Pagès M; Rivier F; Danos O; Garcia L; Claustres M
    Hum Mutat; 2007 Feb; 28(2):196-202. PubMed ID: 17041910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
    Koenig M; Beggs AH; Moyer M; Scherpf S; Heindrich K; Bettecken T; Meng G; Müller CR; Lindlöf M; Kaariainen H; de la Chapellet A; Kiuru A; Savontaus ML; Gilgenkrantz H; Récan D; Chelly J; Kaplan JC; Covone AE; Archidiacono N; Romeo G; Liechti-Gailati S; Schneider V; Braga S; Moser H; Darras BT; Murphy P; Francke U; Chen JD; Morgan G; Denton M; Greenberg CR; Wrogemann K; Blonden LA; van Paassen MB; van Ommen GJ; Kunkel LM
    Am J Hum Genet; 1989 Oct; 45(4):498-506. PubMed ID: 2491009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin or a "related protein" in Duchenne muscular dystrophy?
    Nicholson LV; Johnson MA; Davison K; O'Donnell E; Falkous G; Barron M; Harris JB
    Acta Neurol Scand; 1992 Jul; 86(1):8-14. PubMed ID: 1519480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
    Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
    PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.
    Sherratt TG; Vulliamy T; Dubowitz V; Sewry CA; Strong PN
    Am J Hum Genet; 1993 Nov; 53(5):1007-15. PubMed ID: 8213828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.